Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of two doses of carbetocin with oxytocin for prevention of postpartum bleeding
PACTR202204640411588Completed
- Sponsor
- Rasheedat Balogun
- Start
- May 2022
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of carbetocin and oxytocin in postpartum hemorrhage (PPH) (3 arms), sponsored by Rasheedat Balogun. Primary endpoints: Uterine contractility by palpation and Estimated blood loss. Started May 2022; status: completed.
02
Drugs
carbetocinoxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR202204640411588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202204640411588.